🔗 Share this article

This year's prestigious award in Physiology or Medicine was granted for revolutionary discoveries that illuminate how the immune system targets harmful infections while sparing the body's own cells.

Three esteemed researchers—Japan's Prof. Sakaguchi and US scientists Dr. Brunkow and Dr. Ramsdell—received this honor.

The research uncovered specialized "sentinels" within the immune system that eliminate malfunctioning immune cells that could harming the organism.

These findings are now paving the way for new therapies for immune disorders and cancer.

These winners will share a prize fund valued at 11m Swedish kronor.

Crucial Findings

"The work has been decisive for comprehending how the immune system operates and why we don't all develop severe autoimmune diseases," stated the chair of the Nobel Committee.

The trio's research explain a fundamental question: In what way does the defense system defend us from countless infections while keeping our healthy cells intact?

The immune system employs white blood cells that scan for indicators of disease, even viruses and germs it has not met before.

These cells utilize detectors—called recognition units—that are generated by chance in countless combinations.

That provides the defense network the ability to fight a broad range of invaders, but the unpredictability of the mechanism unavoidably produces immune cells that may target the host.

Protectors of the Immune System

Scientists previously knew that some of these problematic white blood cells were eliminated in the immune organ—where immune cells mature.

This year's award honors the identification of regulatory T-cells—described as the immune system's "peacekeepers"—which travel through the system to disarm other defenders that assault the body's own tissues.

We know that this process malfunctions in autoimmune diseases such as juvenile diabetes, multiple sclerosis, and RA.

The Nobel panel stated, "These findings have laid the foundation for a new field of research and accelerated the development of innovative treatments, for instance for tumors and autoimmune diseases."

In malignancies, regulatory T-cells prevent the system from attacking the growth, so research are focused on reducing their numbers.

In autoimmune diseases, trials are exploring boosting regulatory T-cells so the body is no longer under attack. A similar approach could also be effective in minimizing the risks of organ transplant failure.

Pioneering Experiments

Professor Shimon Sakaguchi, from a Japanese institution, performed experiments on rodents that had their thymus extracted, causing self-attack conditions.

The researcher showed that introducing defense cells from other animals could stop the illness—implying there was a mechanism for blocking defenders from harming the body.

Dr. Brunkow, from the a research center in Seattle, and Fred Ramsdell, currently at a biotech firm in a California city, were investigating an inherited autoimmune disease in mice and people that led to the identification of a genetic factor critical for how T-regs operate.

"Their groundbreaking research has uncovered how the immune system is controlled by T-reg cells, stopping it from mistakenly attacking the healthy cells," commented a prominent biological science specialist.

"This research is a remarkable example of how fundamental biological research can have broad implications for human health."